Lumicell Highlights Growing Role of LumiSystem® as Commercial Expansion Accelerates, including Implementation at Nation's Leading Cancer Center

Summary

Lumicell announced commercial expansion of its LumiSystem® for intraoperative detection of residual breast cancer, highlighting clinical and real-world data supporting its adoption at leading cancer centers as treatment approaches shift toward personalized, de-escalated care.